These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4307060)

  • 21. [On the study of the toxico-infective properties of Cl. perfringens].
    Khazanova VV
    Lab Delo; 1969; 3():164-7. PubMed ID: 4185182
    [No Abstract]   [Full Text] [Related]  

  • 22. Medium for toxin production by Clostridium perfringens in continuous culture.
    Chou G
    Appl Microbiol; 1971 May; 21(5):794-8. PubMed ID: 4324884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of alpha-toxin of Clostridium perfringens in experimental gas gangrene in guinea pigs.
    Kameyama S; Sato H; Murata R
    Jpn J Med Sci Biol; 1972 Jun; 25(3):200. PubMed ID: 4345498
    [No Abstract]   [Full Text] [Related]  

  • 24. [Factors participating in the formation of Cl. perfringens BP6K alpha-toxin in media of determined chemical composition. I. The mechanism of the stimulating effect of an excess of arginine on toxin formation].
    Mekhedov LN
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Aug; 46(8):117-24. PubMed ID: 4311979
    [No Abstract]   [Full Text] [Related]  

  • 25. [Dynamics of the formation of different components of the toxin of Cl. perfringens type A].
    Ispolatovskaia MV; Larina IA; Loseva LP
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Sep; 42(9):110-4. PubMed ID: 4288944
    [No Abstract]   [Full Text] [Related]  

  • 26. [Formation of toxins by Clostridium perfringens types C and D].
    Urguev KR
    Veterinariia; 1970 Jun; 6():98-9. PubMed ID: 4320342
    [No Abstract]   [Full Text] [Related]  

  • 27. [Dynamics of toxin formation in Cl. perfringens types D and E].
    Zemlianiikaia EP; Matveev KI
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Sep; 46(9):102-5. PubMed ID: 4311501
    [No Abstract]   [Full Text] [Related]  

  • 28. [Properties of C1. perfringens toxoids obtained from purified toxins].
    Dmitrieva LN; Shemanova GF; Vlasova EV; Akhundova KA
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Apr; (4):110-4. PubMed ID: 868405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The significance of aerobe mixed infection in gas gangrene. II. The behavior of the Welch-Fraenkel gas gangrene bacillus in aerobic mixed infections (in vivo)].
    Tarbiat S; Grün L
    Zentralbl Chir; 1967 Nov; 92(45):2805-10. PubMed ID: 4298966
    [No Abstract]   [Full Text] [Related]  

  • 30. [Toxins and anatoxins of Clostridium perfringens].
    Cherkas GP; Kalinichenko MF; Biriukova SV; Podgornaia LG
    Mikrobiol Zh; 1971; 33(2):173-5. PubMed ID: 4326475
    [No Abstract]   [Full Text] [Related]  

  • 31. [Fibrinolytic activity of the toxins of Cl. perfringens, Cl. oedematiens and Cl. septicum in mono- and mixed gas infection].
    Zhak SP; Mitskevich AI; Shtefan EE
    Mikrobiol Zh; 1969; 31(3):271-2. PubMed ID: 4311958
    [No Abstract]   [Full Text] [Related]  

  • 32. [Detection of toxins of Clostridium perfringens type A in infected animals by using the ELISA test].
    Nowakowska M; Bartoszcze M; Matras J
    Med Dosw Mikrobiol; 1989; 41(3-4):166-9. PubMed ID: 2561810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunogenic properties of Clostridium perfringens type A anatheta-hemolysin].
    Sergeeva TI; Dolgikh MS; Blagoveshchenskiĭ VA
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Nov; (11):71-5. PubMed ID: 6275640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [DETECTION OF BOTULISM TOXINS AND MICROBES OF B AND C TYPES IN THE BODIES OF SICK HUMAN AND ANIMAL SUBJECTS AND IN CADAVERS].
    SERGEEVA TI
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Jul; 40():77-82. PubMed ID: 14070208
    [No Abstract]   [Full Text] [Related]  

  • 35. [Obtention of Cl. perfringens toxin on a culture medium of casein pancreatic hydrolysate].
    SAMSONOVA VS
    Zh Mikrobiol Epidemiol Immunobiol; 1962 Dec; 33():138-40. PubMed ID: 13976160
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the production of gas gangrene serum in general and of polyvalent gas gangrene aphylacto-serum of the horse especially using the simultaneous immunization method with the 4 known gas gangrene types in uno].
    Becker M
    Arch Exp Veterinarmed; 1967; 21(2):519-46. PubMed ID: 4302817
    [No Abstract]   [Full Text] [Related]  

  • 37. [On the role of lecithinase C in creating immunity to gas gangrene under experimental conditions].
    Larina IA; Ispolatovskaia MV
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Jul; 43(7):125-9. PubMed ID: 4307059
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro tests for the measurement of clostridial toxins, toxoids and antisera. II. Titration of Clostridium perfringens toxins and antitoxins in cell culture.
    Knight PA; Queminet J; Blanchard JH; Tilleray JH
    Biologicals; 1990 Oct; 18(4):263-70. PubMed ID: 2285500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Creation and study of immune antigangrene preparations].
    Papko GF; Sergeeva TI; Rudnitskaia MZ; Egorov VM; Babaĭtseva VA
    Gematol Transfuziol; 1987 Jul; 32(7):20-3. PubMed ID: 2444487
    [No Abstract]   [Full Text] [Related]  

  • 40. FIFTH INTERNATIONAL STANDARD FOR GAS-GANGRENE ANTITOXIN (PERFRINGENS) (CLOSTRIDIUM WELCHII TYPE A ANTITOXIN).
    EVANS DG; PERKINS FT
    Bull World Health Organ; 1963; 29(6):729-35. PubMed ID: 14107745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.